MARSIGLIANTE, Santo
 Distribuzione geografica
Continente #
EU - Europa 12.009
AS - Asia 7.592
NA - Nord America 6.765
SA - Sud America 1.479
AF - Africa 192
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 4
AN - Antartide 1
Totale 28.049
Nazione #
US - Stati Uniti d'America 6.522
IT - Italia 4.157
SG - Singapore 3.612
IE - Irlanda 3.313
RU - Federazione Russa 1.557
CN - Cina 1.311
BR - Brasile 1.242
HK - Hong Kong 1.203
SE - Svezia 843
UA - Ucraina 738
VN - Vietnam 486
DE - Germania 433
IN - India 363
FI - Finlandia 334
KR - Corea 201
GB - Regno Unito 200
CA - Canada 133
AR - Argentina 100
FR - Francia 93
MX - Messico 82
ZA - Sudafrica 78
JP - Giappone 77
PL - Polonia 68
BD - Bangladesh 57
SN - Senegal 51
BE - Belgio 48
EC - Ecuador 43
IQ - Iraq 42
TR - Turchia 40
ES - Italia 38
NL - Olanda 38
CZ - Repubblica Ceca 37
ID - Indonesia 34
LT - Lituania 30
PK - Pakistan 30
IR - Iran 26
AT - Austria 21
PY - Paraguay 20
UZ - Uzbekistan 19
VE - Venezuela 18
AE - Emirati Arabi Uniti 17
CL - Cile 14
MA - Marocco 13
PE - Perù 13
CO - Colombia 12
KE - Kenya 12
BG - Bulgaria 11
CH - Svizzera 10
EG - Egitto 10
IL - Israele 10
BO - Bolivia 9
SA - Arabia Saudita 9
TN - Tunisia 9
DZ - Algeria 8
NP - Nepal 7
UY - Uruguay 7
AL - Albania 6
HU - Ungheria 6
JO - Giordania 6
RS - Serbia 5
TT - Trinidad e Tobago 5
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
EU - Europa 4
JM - Giamaica 4
KW - Kuwait 4
LB - Libano 4
PS - Palestinian Territory 4
RO - Romania 4
AM - Armenia 3
AU - Australia 3
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
BW - Botswana 3
GR - Grecia 3
GT - Guatemala 3
KZ - Kazakistan 3
MY - Malesia 3
NZ - Nuova Zelanda 3
PA - Panama 3
BB - Barbados 2
BN - Brunei Darussalam 2
CG - Congo 2
DK - Danimarca 2
ET - Etiopia 2
GD - Grenada 2
IS - Islanda 2
KG - Kirghizistan 2
MD - Moldavia 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
AO - Angola 1
AQ - Antartide 1
BY - Bielorussia 1
BZ - Belize 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
GE - Georgia 1
GI - Gibilterra 1
Totale 28.034
Città #
Lecce 3.661
Dublin 3.310
Singapore 1.151
Hong Kong 1.115
Chandler 711
Dallas 544
Ashburn 453
Moscow 430
Jacksonville 415
Beijing 332
New York 299
Wayanad 234
Princeton 219
Seoul 198
Ho Chi Minh City 193
Los Angeles 182
Munich 177
São Paulo 143
Des Moines 134
Santa Clara 111
Hanoi 102
Ann Arbor 80
Wilmington 79
Helsinki 78
West Jordan 78
Central District 77
Tokyo 76
Ogden 69
Brooklyn 67
Bari 62
Montreal 61
Warsaw 54
Chicago 53
Denver 53
London 52
Dakar 51
Chennai 50
Frankfurt am Main 50
Lequile 49
Orem 49
Atlanta 46
Boardman 45
Stockholm 45
Brussels 44
Phoenix 44
Poplar 44
Johannesburg 41
Rio de Janeiro 41
Turku 41
Boston 38
Houston 35
Toronto 35
Seelze 34
Mexico City 33
Columbus 31
Kent 30
The Dalles 30
Rome 29
Copertino 28
Jinan 27
San Pietro Vernotico 27
Bremen 26
Falls Church 26
Seattle 26
Guangzhou 25
Manchester 25
San Francisco 25
Falkenstein 24
Ankara 23
Augusta 23
Brno 23
Haiphong 22
Mumbai 22
San Mateo 22
Tianjin 22
Belo Horizonte 20
Da Nang 20
Milan 20
Guarulhos 19
Nuremberg 19
Shanghai 19
Tashkent 19
Amsterdam 18
Querétaro 17
Baghdad 16
Brasília 16
Curitiba 16
Lappeenranta 16
Porto Alegre 16
Leawood 15
Shenyang 15
Zhengzhou 15
Biên Hòa 14
Guayaquil 14
St Louis 14
Aradeo 13
Salvador 13
Vienna 13
Charlotte 12
Ardabil 11
Totale 16.804
Nome #
INJURY PREVENTION IN YOUNG SOCCER PLAYERS: RESULTS OF A PILOT STUDY 231
Exchequer motor game enhances geometric thinking and mood in first grade children 229
ADP sensitizes ZL55 cells to the activity of cisplatin 205
A monoclonal antibody to mammalian Angiotensin II AT1 receptor recognises one of the Angiotensin II receptor isoforms expressed by the eels. 203
[Pt(O,O'-acac)(gamma-acac)(DMS)], a new Pt compound exerting fast cytotoxicity in MCF-7 breast cancer cells via the mitochondrial apoptotic pathway 197
A new platinum(II) complex with high cytotoxicity in human endometrial cancer HeLa cells. 196
A new class of Pt(II) complexes with acetylacetonate as carrier ligand: reactivity and biological behaviour 195
Inhibition of ZL55 cell proliferation by ADP via PKC-dependent signalling pathway 192
[Pt(O,O′-acac)(γ-acac)(DMS)] inhibits malignant pleural mesothelioma cells in vitro and in vivo 191
[Pt(O,O'-acac)(γ-acac)(DMS)] Induces Autophagy in Caki-1 Renal Cancer Cells 188
[Pt(O,O'-acac)(γ-acac)(DMS)] induces autophagy and apoptosis in Skov-3 ovarian carcinoma cells 187
Angiotensin II activates extracellular signal regulated kinases via protein kinase C and epidermal growth factor receptor in breast cancer cells 185
Ionic transports in teleost osmoregulation 183
3,5-Diiodo-l-thyronine induces SREBP-1 proteolytic cleavage block and apoptosis in human hepatoma (Hepg2) cells. 183
[Pt(O,O’-acac)(γ-acac)(DMS)] affects the intracellular Ca2+ homeostasis in MCF-7 breast cancer cells 182
A new platinum (II) complex exerts higher cytotoxicity in tumoral than in normal human breast cells in primary culture. 181
Apoptosis by [Pt(O,O'-acac)(γ-acac)(DMS)] requires PKC-δ mediated p53 activation in malignant pleural mesothelioma 181
A new platinum(II) complex with high cytotoxicity in normal and tumoural thyroid cell lines 179
ADP sensitizes ZL55 cells to the activity of anticancer cisplatin 177
[Pt(O,O’-acac)(γ-acac)(DMS)] exerts high and fast cytotoxicity in breast cancer cells in primary culture 176
Antitumor and Antiangiogenic Activities of [Pt(O,O' acac)(γ-acac)(DMS)] in human renal cell carcinoma 176
[Pt(O,O'-acac)(gamma-acac)(DMS)] alters the expression of genes for cell cycle regulation and invasive function 175
A new platinum(II) complex with high cytotoxicity in human breast cancer MCF-7 cells. 174
Cytotoxic effects of [ Pt( O,O' – acac)(γ-acac)(DMS)] and cisplatin in Caki-1 renal cancer cells 172
A new platinum(II) complex with high cytotoxicity in human breast cancer MCF-7 cells 170
In Vitro and In Vivo Antitumor Activity of [Pt(O,O'-acac)(γ-acac)(DMS)] in Malignant Pleural Mesothelioma 170
Activation of P2Y2 purinoceptor inhibits the activity of the Na+/K+ATPase in HeLa cells 169
PKC-δ/PKC-α activity balance regulates the lethal effects of cisplatin 169
[Pt(O,O’-acac)(γ-acac)(DMS)]: in vivo Studies of a Promising Anticancer Drug in Cancer Therapy 168
Antitumor and antimigration effects of a new Pt compound on neuroblastoma cells 165
[Pt(O,O'-acac)(γ-acac)(DMS)] alters SH-SY5Y cell migration and invasion by the inhibition of Na+/H+ exchanger isoform 1 occurring through a PKC-ε/ERK/mTOR Pathway. 165
3,5,3'TRIIODO-L-THYRONINE INDUCES SREBP-1 EXPRESSION BY NON-GENOMIC ACTIONS IN HUMAN HEP G2 CELLS 163
Antitumor activity of [Pt(O,O’-acac)(γ-acac)(DMS)] in mouse xenograft model of breast cancer 162
Evaluation of the Antitumor Effects of Platinum-Based [Pt(η1-C2H4-OR)(DMSO)(phen)]+ (R = Me, Et) Cationic Organometallic Complexes on Chemoresistant Pancreatic Cancer Cell Lines 160
[Pt(O,O’-acac)(γ-acac)(DMS)]: a comparative study with cisplatin in vivo. 159
Cytotoxicity of new organometallic Pt(II)-complexes containing 1,10-phenantroline 159
1H-NMR metabolomic study of SKOV-3 cells, response to the [Pt(O,O′-acac)(γ-acac)(DMS)] treatment 159
Response of cisplatin resistant SkOV-3 cells to [PT(O,O'-Acac)(γ-Acac)(DMS)] Treatment revealed by a metabolomic 1H-NMR study 158
Angiotensin II stimulates the Na+/H+ exchanger in human umbilical vein endothelial cells via AT1 receptor 157
A filtration-based real-time PCR method for the quantitative detection of viable Salmonella enterica and Listeria monocytogenes in food samples. 157
Different apoptotic effects of [Pt(O,O'-acac)(γ-acac)(DMS)] and cisplatin on normal and cancerous human epithelial breast cells in primary culture. 157
Cisplatin-analogous β-diketonate Pt(II) organometallic species: reactivity and cytotoxicity 156
[Pt(O,O’-acac)(γ-acac)(DMS)] inhibits adhesion and migration of breast cancer cells 156
B-DIKETONATE PLATINUM(II) COMPLEXES SHOWING HIGHER CYTOTOXIC ACTIVITY THAN CISPLATIN ON CANCER CELLS. 155
Angiotensin II receptor subtypes in eel (Anguilla anguilla) 155
Referees' physical performance over a soccer season 154
4 S oestrogen receptor isoforms and their distribution in breast cancer samples 152
Activation of P2Y2 receptor induces C-Fos protein through a pathway Involving Mitogen-Activated Protein Kinase and phosphoinositide 3-kinases in HeLa cells. 152
[Pt(O,O′-acac)(γ-acac)(DMS)] inhibits migration of tumor human breast cells in primary cultures 152
The effects of exercise training on lipid metabolism and coronary heart disease 152
Antitumor and antimigration effects of Salvia clandestina L. extract on osteosarcoma cells 152
Antitumor Effects Induced by the Promising Drug [Pt(O,O′-acac)(γ-acac)(DMS)] in Cisplatin Resistant Epithelial Ovarian Carcinoma Cell Line (SKOV-3): a 1H NMR Metabolomic Study 150
Is mitochondrial DNA profiling predictive for athletic performance? 149
A NMR-Based Metabolomic Approach to Investigate the Antitumor Effects of the Novel [Pt(η1-C2H4OMe)(DMSO)(phen)]+ (phen = 1,10-Phenanthroline) Compound on Neuroblastoma Cancer Cells 148
Activation of angiotensin II type I receptor promotes protein kinase C translocation and cell proliferation in human cultured breast epithelial cells 147
An L-proline-dependent proton flux is located at the apical membrane level of the eel enterocytes. 147
Cytotoxicity of [Pt(O,O’-acac)(γ-acac)(DMS)] in normal and cancerous human breast cells in primary culture 146
Differential functions of PKC-delta and PKC-zeta in cisplatin response of normal and transformed thyroid cells. 144
A novel monoclonal antibody to a plasmamembrane-located breast cancer antigen Interferes with the proliferation rate of cancerous cells in vitro 141
Angiotensin II stimulation of the basolateral located Na/H antiporter in eel (Anguilla anguilla) enterocytes 140
Multiple isoforms of the oestrogen receptor in endometrial cancer 139
Computerised counting of the tumour infiltrating lymphocytes in ninety breast cancer specimens. 139
Differential response of normal, dedifferentiated and transformed thyroid cell lines to cisplatin treatment 139
[Pt(O,O’-acac)(γ-acac)(DMS)] induces apoptosis in human breast cancer cells in primary culture 139
Multiple pathways for cationic amino acid transport in rat thyroid epithelial cell line PC Cl3 138
Cisplatin activates the PKC/ERK1/2 intracellular transduction pathways in rat thyroid PC Cl3 cells 138
The Angiosuppressive Effects of [Pt(O,O′-acac)(γ-acac)(DMS)] 138
Different regulation of matrix metalloproteinase-2 in cisplatin response of normal and transformed thyroid cells 137
Bradykinin stimulates prostaglandin E2 release in human skeletal muscular fibroblasts 137
Cytotoxic Activity of New β-Diketonate Platinum(II) Complexes on Cancer Cells 136
Mitochondria-mediated apoptosis by a new Pt(II) compound, [Pt(O,O’-acac)(g-acac) (DMS)], in human breast cancer cells 136
CCL20 promotes migration and invasiveness of human cancerous breast epithelial cells in primary culture 136
NEW B-DIKETONATE PT(II) ORGANOMETALLIC SPECIES EXHIBITING HIGHER CYTOTOXIC ACTIVITY ON CANCER CELLS THAN CISPLATIN. 135
The effects of training on hormonal concentrations in young soccer players 135
NMR-based metabolomic analyses of cisplatin resistant SKOV-3 cell line response to [Pt (O,O′-acac)(γ-acac)(DMS)], Ptac2S, treatment: comparison to cisplatin 135
Protein kinase C-delta mediates cisplatin-induced apoptosis of ZL55 mesothelioma cells 133
Monitoring Psychometric States of Recovery to Improve Performance in Soccer Players: A Brief Review 132
Effect of tumour size on the association between pS2 and cathepsin D in primary breast cancer 132
Characterization of Na+/H+ antiporter activity in PC-Cl3 thyroid cells 132
Adenosine diphosphate regulates MMP2 and MMP9 activity in malignant mesothelioma cells 131
AT1 angiotensin II receptor subtype in the human larynx and squamous laryngeal carcinoma 130
Biological interest of four -coordinate complexes of platinum with Bathophenanthroline and Bathocuproine sulfonates 130
Involvement of Protein Kinase Cdelta and -epsilon in cisplatin-induced apoptosis in thyroid cells. 130
A new platinum(II) compound anticancer drug candidate with selective cytotoxicity for breast cancer cells 130
Purinergic receptors in a pleural mesotelioma cell line. 130
Increase of [Ca2+]i via activation of ATP receptors in PC-Cl3 rat thyroid cell line 128
Sintesi e caratterizzazione di nuovi analoghi del cisplatino conformazionalmente stabilizzati. 128
Synthesis, characterization and cytotoxic activity of novel Pt(II) complexes with acetylacetonate and amines 128
Angiotensin II AT1 Receptor Stimulates Na+/K+ATPase Activity Through a Pathway Involving PKC-z in Rat Thyroid Cells. 127
Synthesis, characterization, intercalating ability and in vitro cytotoxic activity of new mononuclear and homodinuclear Pt(II) complexes. 127
Immunolocalization of the AT-1R Ang II Receptor in Human Kidney Cancer 125
EGFR MEDIATES THE CYTOTOXICITY OF CISPLATIN IN THE DIFFERENTIATED RAT THYROID PC CL3 CELL LINE THROUGH THE ACTIVATION OF MAPK/P38 125
Synthesis and characterization of new water-soluble organometallic complexes of the type [PtL(h1-C2H4OMe)(N^N)] (L = NH3, DMSO; N^N = dinitrogen ligand) with potential antitumor activity 125
Dopamine and antioxidant grape seed extract loaded chitosan nanoparticles: A preliminary in vitro characterization. 124
PKC-epsilon-dependent cytosol-to-membrane translocation of pendrin in rat thyroid PC Cl3 cells. 124
Immunolocalisation of angiotensin II receptors in icefish (Chionodraco hamatus) tissues. 124
Expression of cathepsin D in malignant and in the corresponding non-malignant node-negative laryngeal samples: Correlation with receptors for androgen, glucocorticoid, oestrogen and progesterone 123
New mononuclear and homodinuclear Pt(II) complexes with heterocyclic nitrogen chelates: Synthesis, characterization, intercalating ability and in vitro cytotoxic activity evaluation 123
β-Diketonate Platinum(II) Complexes Showing Higher Cytotoxic Activity than Cisplatin on Cancer Cells. 123
Oestrogen receptor isoforms, their distribution and relation to progesterone receptor levels in breast cancer samples 122
Totale 15.396
Categoria #
all - tutte 132.949
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 132.949


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.062 0 0 0 0 0 207 10 212 38 223 164 208
2021/20221.011 16 7 80 96 153 16 26 73 23 63 151 307
2022/20235.720 259 410 207 208 228 351 33 273 3.517 13 145 76
2023/20241.801 157 102 127 98 134 174 22 61 262 374 205 85
2024/20256.131 104 33 133 101 386 740 187 294 2.042 614 563 934
2025/20268.278 1.303 1.750 1.306 1.928 1.429 562 0 0 0 0 0 0
Totale 28.392